Decker, M., Bannon, A., Curzon, P., Gunther, K., Brioni, J., Holladay, M., … Arneric, S. (1997). ABT-089 2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride : II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys. The Journal of Pharmacology and Experimental Therapeutics, 283(1), 247-58. Retrieved from https://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=9336330

Briggs, C., Anderson, D., Brioni, J., Buccafusco, J., Buckley, M., Campbell, J., … Arneric, S. (1969). Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacology, Biochemistry, and Behavior, 57(1-2), 231-41. https://doi.org/10.1016/s0091-3057(96)00354-1 (Original work published 1969)

Lin, N., Gunn, D., Ryther, K., Garvey, D., Donnelly-Roberts, D., Decker, M., … Holladay, M. (1997). Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing properties. Journal of Medicinal Chemistry, 40(3), 385-90. https://doi.org/10.1021/jm960233u (Original work published 1997)